Offers formulation development across a U.S., U.K., and Indian network, with publicly listed nanosuspension, microemulsion, ASD, oral solid, and sterile injectable capabilities.
IndiaFull profile →
Formulation Development & Manufacturing · Companies
Matching companies load automatically. Browse 24 companies per page; expand filters to narrow the results.
Search & refine Filters update automatically
Disease tags identify mentions in recorded facts or pipeline text, not approved indications or a complete pipeline. Platform service providers may have no disease-specific tag.
44 matching companiesShowing 25–44 / 44
The development business supports early formulation through registration-batch scale-up and regulatory submissions. Injectable development at Leiden and other sites connects with the group's manufacturing network.
FranceFull profile →
Discloses development from preformulation through final formulation and analytical methods, with expanded bioavailability enhancement for poorly soluble drugs and clinical trial support.
GermanyFull profile →
The group has both proprietary drug and CDMO businesses. Publicly disclosed CDMO services cover development and manufacturing of complex oral solids, liquids, semisolids, biologics, and sterile injectables.
Taiwan, ChinaFull profile →
Biologics formulation and optimization services include computational analysis, excipient screening, stability, packaging, and high-concentration and in-use studies. The CDMO business is part of the FUJIFILM group.
JapanFull profile →
CMIC's drug product CDMO services cover preformulation, process and analytical development, clinical materials, and commercial supply. Official materials identify CMIC CDMO as part of the Dai Nippon Printing group.
JapanFull profile →
Offers clinical and commercial contract manufacturing for oral solids and injectables, and describes CMC development spanning process and formulation design, analytical work, and regulatory submissions.
JapanFull profile →
Oral dosage development combines spray-dried ASD, HME, particle size reduction, lipid formulations, and controlled release, spanning preclinical and clinical supply through commercial scale-up.
United StatesFull profile →
LTS completed its acquisition of the former Renaissance Lakewood business in November 2025 and integrated it into the Nasal & Sterile Drug Products division, offering nasal spray and sterile dosage form R&D and manufacturing.
United StatesFull profile →
Canadian contract development and manufacturing services include formulation development, comprehensive physicochemical characterization, development of simple and complex sterile formulations, and aseptic fill-finish.
CanadaFull profile →
Offers formulation and process concept design, preformulation, development, and manufacturing, with additional disclosed expertise in semisolid and ophthalmic dosage forms.
United KingdomFull profile →
Specializes in single- and multidose liquid CDMO services, including eye drops, BFS unit doses, and oral liquid stick packs. The Bordeaux development page lists formulation and analytical development for solutions, suspensions, gels, and emulsions.
FranceFull profile →
Current disclosures include early drug product services at Longmont, including preformulation, FIH capsules and bottles, immediate-release, and enteric or extended-release products. The Mirabel/Whippany drug product businesses were sold in 2023, so their historical commercial network is excluded.
United StatesFull profile →
Offers formulation and analytical services for small and large molecules, with publicly listed injectable solutions, suspensions, emulsions, lyophilized products, and oral formulation prototypes.
United StatesFull profile →
A CRO specializing in biologic drug products, offering early- through late-stage formulation and analytical development for high-concentration, liquid, and lyophilized products; U.S. laboratory operations were publicly disclosed in 2026.
GermanyFull profile →
Offers data science-assisted biologics formulation, lyophilization, and viral vector formulation services. Small-scale non-GMP production and commercial GMP manufacturing require separate confirmation.
GermanyFull profile →
Biologics CDO services include cell line, process, analytical, and drug product formulation development, with a disclosed high-concentration formulation platform.
South KoreaFull profile →
A biologics CDMO offering analytical and formulation development. Seattle is identified as a formulation center for liquid, lyophilized, and high-concentration drug products.
Japan / United States / GermanyFull profile →
Offers liquid, lyophilized, and complex injectable formulation development, compatibility and stability studies, and clinical-to-commercial sterile manufacturing for small molecules and biologics.
United StatesFull profile →
The official annual report lists formulation development services. Recent technical job descriptions disclose preclinical and clinical formulation work and protein biologic formulation screening, process development, and transfer capabilities.
IndiaFull profile →
Coverage expands from sourced records; this database does not claim all biopharma companies.